LON:POLX - Polarean Imaging Share Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Polarean Imaging PLC Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add GBX 21.50 0.00 (0.00 %) (As of 03/27/2020 04:00 PM ET) Add Compare Today's Range 20.25Now: GBX 21.50▼ 22.2550-Day Range 17.50MA: GBX 23.92▼ 3252-Week Range 13Now: GBX 21.50▼ 39.50Volume12,445 shsAverage VolumeN/AMarket Capitalization£24.60 millionP/E RatioN/ADividend YieldN/ABetaN/A ProfileAnalyst RatingsAdvanced ChartHeadlines Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Polarean Imaging Plc operates as a medical drug-device combination company serving the medical imaging market in the United States and internationally. The company manufactures, sells, and services hyperpolarizers and ancillary equipment for biomedical imaging research. It develops equipment that enables existing magnetic resonance imaging (MRI) systems to achieve a level of pulmonary functional imaging and specializes in the use of hyperpolarized Xenon gas (129Xe) as an imaging agent to visualize ventilation and gas exchange regionally in the smallest airways of the lungs, the tissue barrier between the lung and the bloodstream, and in the pulmonary vasculature; and a novel diagnostic approach. The company also develops and manufactures MRI radiofrequency coils, which are required components for imaging 129Xe in the MRI system. Polarean Imaging Plc was founded in 2011 and is based in London, the United Kingdom.Read More Industry, Sector and Symbol Stock Exchange LON Industry Medical Devices Sub-IndustryN/A SectorMedical Current SymbolLON:POLX Previous Symbol CUSIPN/A CIKN/A Webhttp://www.polarean.com/ PhoneN/ADebt Debt-to-Equity Ratio3.56 Current Ratio1.54 Quick Ratio1.01Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales£1.81 million Price / Sales13.58 Cash FlowGBX 1.47 per share Price / Cash Flow14.62 Book ValueGBX 4.60 per share Price / Book4.67Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees13 Outstanding Shares114,439,000Market Cap£24.60 million Next Earnings DateN/A OptionableNot Optionable Receive POLX News and Ratings via Email Sign-up to receive the latest news and ratings for POLX and its competitors with MarketBeat's FREE daily newsletter. LSE:POLX Rates by TradingView Polarean Imaging (LON:POLX) Frequently Asked Questions How has Polarean Imaging's stock been impacted by COVID-19 (Coronavirus)? Polarean Imaging's stock was trading at GBX 20.50 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, POLX shares have increased by 4.9% and is now trading at GBX 21.50. View which stocks have been mosted impacted by Coronavirus. Has Polarean Imaging been receiving favorable news coverage? Press coverage about POLX stock has trended somewhat positive recently, according to InfoTrie Sentiment Analysis. The research firm scores the sentiment of news coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Polarean Imaging earned a media sentiment score of 0.8 on InfoTrie's scale. They also assigned media headlines about the company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an impact on the stock's share price in the next several days. View the latest news aboutPolarean Imaging. Who are some of Polarean Imaging's key competitors? Some companies that are related to Polarean Imaging include Cyclopharm (CYC), Electromed (ELMD), Imricor Med SYS Cdi 1:1 US Person Prohibited Excluding QIB (IMR), REVA Medical (RVA), Advanced Oncotherapy (AVO), Patient Home Monitoring (PTQ), Protech Home Medical (PHM), MRI Interventions (MRIC), Oventus Medical (OVN), Kromek Group (KMK), Resonance Health (RHT), Respiri (RSH), Avacta Group (AVCT), EMvision Medical Devices (EMV) and GI Dynamics (GID). What other stocks do shareholders of Polarean Imaging own? Based on aggregate information from My MarketBeat watchlists, some companies that other Polarean Imaging investors own include Allena Pharmaceuticals (ALNA), Ampliphi Biosciences (APHB), Arbutus Biopharma (ABUS), AcelRx Pharmaceuticals (ACRX), Aldeyra Therapeutics (ALDX), Apellis Pharmaceuticals (APLS), Aquinox Pharmaceuticals (AQXP), Ardelyx (ARDX), ArQule (ARQL) and Athersys (ATHX). Who are Polarean Imaging's key executives? Polarean Imaging's management team includes the following people: Mr. Clairis Richard Hullihen, CEO & Director (Age 66)Mr. William F. Patrick Jr., Chief Financial Officer (Age 57)Mr. Kenneth Paul West, COO & Director (Age 62)Mr. Bastiaan Driehuys Ph.D., CTO & Director (Age 50)Mr. Stephen Austin, Company Sec. What is Polarean Imaging's stock symbol? Polarean Imaging trades on the London Stock Exchange (LON) under the ticker symbol "POLX." How do I buy shares of Polarean Imaging? Shares of POLX and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What is Polarean Imaging's stock price today? One share of POLX stock can currently be purchased for approximately GBX 21.50. How big of a company is Polarean Imaging? Polarean Imaging has a market capitalization of £24.60 million and generates £1.81 million in revenue each year. Polarean Imaging employs 13 workers across the globe. View additional information about Polarean Imaging. What is Polarean Imaging's official website? The official website for Polarean Imaging is http://www.polarean.com/. MarketBeat Community Rating for Polarean Imaging (LON POLX)Community Ranking: 2.4 out of 5 ( )Outperform Votes: 22 (Vote Outperform)Underperform Votes: 23 (Vote Underperform)Total Votes: 45MarketBeat's community ratings are surveys of what our community members think about Polarean Imaging and other stocks. Vote "Outperform" if you believe POLX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe POLX will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 3/28/2020 by MarketBeat.com StaffFeatured Article: Book Value Per Share in Stock Trading
